Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRI) Equity Average (2021 - 2025)

Historic Equity Average for Biofrontera (BFRI) over the last 5 years, with Q3 2025 value amounting to -$3.6 million.

  • Biofrontera's Equity Average fell 14409.1% to -$3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.6 million, marking a year-over-year decrease of 14409.1%. This contributed to the annual value of $4.6 million for FY2024, which is 6782.11% down from last year.
  • Latest data reveals that Biofrontera reported Equity Average of -$3.6 million as of Q3 2025, which was down 14409.1% from -$2.1 million recorded in Q2 2025.
  • In the past 5 years, Biofrontera's Equity Average registered a high of $23.2 million during Q4 2022, and its lowest value of -$3.6 million during Q3 2025.
  • For the 5-year period, Biofrontera's Equity Average averaged around $7.7 million, with its median value being $3.9 million (2023).
  • Data for Biofrontera's Equity Average shows a peak YoY increase of 89181.38% (in 2025) and a maximum YoY decrease of 17585.08% (in 2025) over the last 5 years.
  • Biofrontera's Equity Average (Quarter) stood at -$3.0 million in 2021, then skyrocketed by 869.17% to $23.2 million in 2022, then tumbled by 87.45% to $2.9 million in 2023, then soared by 70.86% to $5.0 million in 2024, then crashed by 172.76% to -$3.6 million in 2025.
  • Its Equity Average stands at -$3.6 million for Q3 2025, versus -$2.1 million for Q2 2025 and $2.5 million for Q1 2025.